Latest Taxation News

Page 3 of 35
Actinogen Medical has received an A$10.84 million R&D tax rebate, leaving it with A$21.9 million in pro forma cash and no debt just weeks before its pivotal Alzheimer’s readout. The company says topline XanaMIA results remain due in mid-November.
Ada Torres
Ada Torres
26 Oct 2026
FAR’s remaining value is tied largely to Woodside’s Sangomar production and oil prices, with up to US$19.8 million still potentially payable after a US$23.7 million provisional receipt. The oil and gas company ended September with US$1.73 million in unaudited cash and no exploration expenditure.
Victor Sage
Victor Sage
23 Oct 2026
Amplia Therapeutics has received an A$4.78 million refundable R&D tax rebate, giving the clinical-stage biotechnology company additional cash to advance its FAK inhibitor programs. The funds will support multiple narmafotinib trials and related research, including studies involving Lilly.
Victor Sage
Victor Sage
22 Oct 2026
The Australian Taxation Office has confirmed that Mantle Minerals’ $0.001 per share capital return was not a dividend or ordinary income for eligible shareholders. The ruling provides a clearer framework for the capital gains tax treatment of the payment made in November 2025.
Maxwell Dee
Maxwell Dee
21 Oct 2026
Janus Electric has used a A$1.91 million FY2026 R&D tax refund to cut its Rockford loan balance to A$987,000. The repayment is expected to reduce interest costs by about A$325,000 a year, while a further overseas R&D refund remains subject to approval.
Victor Sage
Victor Sage
20 Oct 2026
ECS Botanics has delivered a fifth consecutive quarter of positive operating cash flow, while branded sales and international expansion continue to reshape the business. The next test is whether planned UK and Polish launches can convert into recurring revenue.
Ada Torres
Ada Torres
19 Oct 2026
FleetPartners has agreed to a $1.131 billion cash takeover by SG Fleet after a competitive auction lifted the offer to $5.30 per share. The deal still requires shareholder, court and regulatory approval, with completion targeted for March 2027.
Victor Sage
Victor Sage
19 Oct 2026
Latrobe Magnesium says its Phase 1B demonstration plant is 95% installed and 35% commissioned, keeping first magnesium metal crowns above 98% purity on track for the end of 2026. The operational advance comes alongside a tight funding position, an extended A$3.4 million entitlement offer and an ambitious South Carolina expansion plan.
Victor Sage
Victor Sage
16 Oct 2026
Otto Energy has strengthened its balance sheet and lifted FY2026 profit despite falling production, setting up a proposed A$20 million return of capital. The catch is that reserves are declining, asset-sale plans remain unresolved and part of the cash remains tied to offshore obligations.
Victor Sage
Victor Sage
14 Oct 2026
Excite Technology Services has reported its strongest quarterly operating cash flow on record, with A$1.33 million generated in the September quarter and cash reserves rising to A$3.98 million. The result was supported by stronger customer receipts, a A$3.20 million Federal Government digital forensics contract and a July capital raising.
Victor Sage
Victor Sage
14 Oct 2026
Inghams Group Limited (ASX:ING) returned to poultry volume growth in FY26, but rising costs, a tax dispute and weaker earnings sharply reduced shareholder returns. The company enters FY27 with lower net debt, elevated leverage and a value-led turnaround strategy still to prove itself.
Victor Sage
Victor Sage
9 Oct 2026
The ATO has confirmed that two Senetas shareholder distributions totalling approximately $5.5 million should be treated as returns of capital rather than dividends for eligible Australian-resident investors. Any tax withheld from those payments is due to be returned within 14 days.
Victor Sage
Victor Sage
7 Oct 2026

Browse the archive

Full archive